Protein Tyrosine Kinases
-
Dasatinib (BMS-354825)
Catalog No. A10290 Abl-Src 抑制剂Dasatinib (BMS-354825)是一种口服多BCR/ABL和Src家族酪氨酸激酶抑制剂。Dasatinib (BMS-354825)的主要靶标是BCR/ABL,Src,c-Kit,ephrin受体和其他几种酪氨酸激酶,但不是erbB激酶,例如EGFR或Her2。 了解更多 -
Saracatinib (AZD0530)
Catalog No. A10108 Src/Abl 抑制剂Saracatinib (AZD0530)是一种高选择性,双特异性Src/Abl激酶抑制剂,对c-Src和Abl激酶的IC50分别为2.7和30 nM。 了解更多 -
Bosutinib (SKI-606)
Catalog No. A10161 -
NVP-BHG712
Catalog No. A10661 EphB4 抑制剂NVP-BHG712是EphB4激酶的选择性抑制剂,在体外对EphB4的选择性超过40多种其他激酶(包括FGFR3)。 了解更多 -
PD-166285
Catalog No. A13868 -
Dasatinib hydrochloride
Catalog No. A15060 Src 抑制剂Dasatinib hydrochloride是一种有效的Abl/Src双重抑制剂,IC50分别<1 nM/0.8 nM。还可以抑制c-Kit(WT/c-Kit(D816V),IC50为79 nM/37 nM。有效,选择性Raf激酶抑制剂能够抑制野生型B-Raf,B-RafV600E和c -Raf的IC50值分别为3.2、0.8和5.0 nM。 了解更多 -
KX2-391 2HCl
Catalog No. A11471 Src 抑制剂Tirbanibulin dihydrochloride是首个靶向Src肽底物位点的临床Src抑制剂(拟肽类),在癌细胞系中GI50为9-60 nM。 了解更多 -
AZM475271
Catalog No. A16241 -
T338C Src-IN-1
Catalog No. A16243 Src 抑制剂T338C Src-IN-1是有效的Src T338C突变体抑制剂。相对于WT c-Src(增加10倍),T338C(IC50 = 111 nM)的抑制作用最强。 了解更多 -
T338C Src-IN-2
Catalog No. A16244 Src 抑制剂T338C Src-IN-2是有效的突变c-Src T338C激酶抑制剂,IC50为317 nM;它还抑制T338C/V323A和T338C/V323S,IC50为57 nM/19 nM。 了解更多 -
Quercetin (Sophoretin)
Catalog No. A10766 MAO-B 抑制剂Quercetin (Sophoretin)抑制许多酶系统,包括酪氨酸蛋白激酶,磷脂酶A2,磷酸二酯酶,线粒体ATPase,PI 3-激酶和蛋白激酶C。 了解更多 -
1-NA-PP1
Catalog No. A13232 -
CGP77675
Catalog No. A13821 -
TC-S 7003 (Lck Inhibitor)
Catalog No. A15140 -
Lck inhibitor 2
Catalog No. A15141 Lck 抑制剂Lck inhibitor 2 是酪氨酸激酶的双苯胺基嘧啶抑制剂,包括LCK,BTK,LYN,SYK和TXK。Lck,Btk,Lyn,Btk和Txk的IC50值分别为13nM,9nM,3nM,26nM和2nM。 了解更多 -
Tilfrinib
Catalog No. A16086 -
Lyn-IN-1
Catalog No. A16265 -
KIN001-051
Catalog No. A16923 Lck 抑制剂KIN001-051是一种有效的、选择性的Lck抑制剂。淋巴细胞特异性蛋白酪氨酸激酶(Lck)是非受体蛋白酪氨酸激酶Src家族的成员,在触发细胞因子产生的T细胞受体信号转导的初始步骤中起着至关重要的作用。 了解更多 -
CHMFL-KIT-033
Catalog No. A18476 c-KIT T670I mutant inhibitorCHMFL-KIT-033 is a potent and selective inhibitor of c-KIT T670I mutant for gastrointestinal stromal tumors (GISTs), with an IC50 of 0.045 μM. 了解更多 -
c-Kit-IN-2
Catalog No. A18440 c-KIT inhibitorc-Kit-IN-2 is a c-KIT inhibitor with an IC50 of 82 nM, shows superior antiproliferative activities against all the three GIST cell lines, GIST882, GIST430, and GIST48, with GI50s of 3, 1, and 2 nM, respectively. 了解更多 -
CHMFL-ABL/KIT-155
Catalog No. A12421 ABL/c-KIT dual kinase inhibitorCHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155; compound 34) is a highly potent and orally active type II ABL/c-KIT dual kinase inhibitor. 了解更多 -
PLX647
Catalog No. A15519 -
AZD3229 Tosylate
Catalog No. A16867 -
Tie2 kinase inhibitor
Catalog No. A10932 -
Pexmetinib (ARRY-614)
Catalog No. A10895 p38 MAPK 抑制剂Pexmetinib (ARRY-614)是通过双重抑制p38促分裂原活化蛋白激酶(MAPK)和Tie2/Tek受体酪氨酸激酶,其在HEK-293细胞中的IC50分别为4 nM/18 nM。Pexmetinib是一种有效的细胞因子合成抑制剂。 了解更多 -
Tyrosine kinase inhibitor
Catalog No. A15267 Tyrosine kinase 抑制剂Tyrosine kinase inhibitor是一种抑制酪氨酸激酶的药物。酪氨酸激酶是负责通过信号转导级联反应激活许多蛋白质的酶。 了解更多 -
ANA-12
Catalog No. A13877 -
LOXO-101 (ARRY-470, Larotrectinib)
Catalog No. A15974 -
GW 441756
Catalog No. A16238 -
LOXO-101 sulfate
Catalog No. A16239 TRK 抑制剂LOXO-101 sulfate是一种小分子,设计用于阻断TRK家族的ATP结合位点,对TRKA,TRKB和TRKC激酶具有2至20 nM的细胞效力。 了解更多 -
AZ 23
Catalog No. A12666 -
Sitravatinib (MGCD516)
Catalog No. A16259